Mandate

Vinge advises Fidelio Capital in the divestment of a minority stake in Odevo to CVC Capital Partners

Vinge has advised Fidelio Capital (“Fidelio”) and the other shareholders of Odevo Group (“Odevo”) in connection with the divestment of a minority shareholding to funds controlled by CVC Capital Partners (“CVC”). Fidelio, the existing management team and other minority shareholders of Odevo will retain a majority holding in the company.

Odevo has built an organisation which, supported by a bespoke tech-platform, helps residential property owners manage all aspects of their building, ranging from accounting, administration, invoicing and on-site services to renovations. The company was founded in Sweden in 2018 by the investment firm Fidelio and the current management team. Through organic growth and joining forces with more than 50 successful entrepreneurs across Europe and USA, Odevo has expanded the business more than 50x, now managing 1.4 million homes with more than 7,000 employees and an annual turnover of EUR 650 million. By welcoming CVC to the group of investors, Odevo takes yet another step on its international growth journey.

The transaction is subject to applicable regulatory and antitrust approvals.

Vinge’s team consisted of Jonas Bergström, Johanna Wiberg, Anna Jonsson, Elsie Nassar, Amanda Steen, Philip Moré, Lovisa Jonassen and Matilda Hamner (M&A), Nils Unckel and Anton Sjökvist (Financial Regulatory), Sebastian Örndahl and Alva Chambert (EU, Competition and Regulatory), Mathilda Persson, Jolene Reimerson and Siri Blomberg (Commercial Agreements, IT and GDPR), Rebecka Målquist (Intellectual Property), Mia Falk and Gulestan Ali (Compliance), Emelie Schoning, Emy Rydén, Gabriella Balbo and Ottilia Pettersson (Transaction Support Coordinators).

Read the client’s press release here.

Related

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge advises Studentbostäder i Norden AB (publ) in connection with its issuance of bonds in an amount of SEK 500 million and its early redemption of outstanding bonds

Vinge has advised Studentbostäder i Norden AB (publ) in connection with its issuance of senior unsecured bonds in an amount of SEK 500 million (within a framework of SEK 750 million) and in parallel with the company's voluntary early redemption of previously issued bonds.
March 12, 2026